Pharma Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Law Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

National Taiwan University, Taiwan

Recent findings in rectal cancer described by researchers from Taiwan and France

Study 1: Laparoscopic abdominoperineal resection (APR) can be performed with good technical efficiency, quick functional recovery, and mild disability.

"The appropriateness of the laparoscopic approach for the resection of rectal cancer has been controversial, although it is well established in colon cancer. This is a phase II study of laparoscopic APR in the treatment of lower rectal cancers. Patients with lower rectal adenocarcinoma located within 6 cm above the anal verge were recruited and subjected to laparoscopic APR," scientists in Taiwan report.

...

• View Other Issues of Pharma Law Weekly
  
• View Other NewsRx Publications